Common
Cagrilintide/semaglutide
Combination drug
Cagrilintide/semaglutide
Cagrilintide/semaglutide, known as CagriSema, is a combination of cagrilintide, a dual amylin and calcitonin receptor agonist, and semaglutide, a GLP-1 agonist. It has been proposed as a follow-on to semaglutide (alone) or tirzepatide in treatments for obesity and type II diabetes.
Open boosters, collect cards and trade them. Free to play.
Play for free